170 related articles for article (PubMed ID: 32143728)
21. How to develop cost-conscious guidelines.
Eccles M; Mason J
Health Technol Assess; 2001; 5(16):1-69. PubMed ID: 11427188
[TBL] [Abstract][Full Text] [Related]
22. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
Brettschneider C; Lühmann D; Raspe H
GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
[TBL] [Abstract][Full Text] [Related]
23. Adaptive trials for tuberculosis: early reflections on theory and practice.
Montgomery CM
Int J Tuberc Lung Dis; 2016 Aug; 20(8):1091-8. PubMed ID: 27393545
[TBL] [Abstract][Full Text] [Related]
24. Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project.
Lord J; Willis S; Eatock J; Tappenden P; Trapero-Bertran M; Miners A; Crossan C; Westby M; Anagnostou A; Taylor S; Mavranezouli I; Wonderling D; Alderson P; Ruiz F
Health Technol Assess; 2013 Dec; 17(58):v-vi, 1-192. PubMed ID: 24325843
[TBL] [Abstract][Full Text] [Related]
25. Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials.
Dimairo M; Julious SA; Todd S; Nicholl JP; Boote J
Trials; 2015 Dec; 16():585. PubMed ID: 26700741
[TBL] [Abstract][Full Text] [Related]
26. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.
Bryan S; Williams I; McIver S
Health Econ; 2007 Feb; 16(2):179-93. PubMed ID: 16960851
[TBL] [Abstract][Full Text] [Related]
27. Health economics methods for public health resource allocation: a qualitative interview study of decision makers from an English local authority.
Frew E; Breheny K
Health Econ Policy Law; 2020 Jan; 15(1):128-140. PubMed ID: 30632474
[TBL] [Abstract][Full Text] [Related]
28. Closing the cycle of innovation in healthcare in Europe.
Hulstaert F; Ruether A; Demotes J; Melien Ø
Int J Technol Assess Health Care; 2020 Apr; 36(2):75-79. PubMed ID: 31948497
[TBL] [Abstract][Full Text] [Related]
29. Economic evaluations of health technologies in Dutch healthcare decision-making: a qualitative study of the current and potential use, barriers, and facilitators.
Roseboom KJ; van Dongen JM; Tompa E; van Tulder MW; Bosmans JE
BMC Health Serv Res; 2017 Jan; 17(1):89. PubMed ID: 28126005
[TBL] [Abstract][Full Text] [Related]
30. Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov.
Bothwell LE; Avorn J; Khan NF; Kesselheim AS
BMJ Open; 2018 Feb; 8(2):e018320. PubMed ID: 29440155
[TBL] [Abstract][Full Text] [Related]
31. Systematic reviews and economic evaluations conducted for the National Institute for Health and Clinical Excellence in the United Kingdom: a game of two halves?
Drummond MF; Iglesias CP; Cooper NJ
Int J Technol Assess Health Care; 2008; 24(2):146-50. PubMed ID: 18400116
[TBL] [Abstract][Full Text] [Related]
32. Digital interventions in mental health: evidence syntheses and economic modelling.
Gega L; Jankovic D; Saramago P; Marshall D; Dawson S; Brabyn S; Nikolaidis GF; Melton H; Churchill R; Bojke L
Health Technol Assess; 2022 Jan; 26(1):1-182. PubMed ID: 35048909
[TBL] [Abstract][Full Text] [Related]
33. Attitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) project.
Meurer WJ; Legocki L; Mawocha S; Frederiksen SM; Guetterman TC; Barsan W; Lewis R; Berry D; Fetters M
Trials; 2016 Jul; 17():373. PubMed ID: 27473126
[TBL] [Abstract][Full Text] [Related]
34. Bone graft substitutes for the treatment of traumatic fractures of the extremities.
Hagen A; Gorenoi V; Schönermark MP
GMS Health Technol Assess; 2012; 8():Doc04. PubMed ID: 22984371
[TBL] [Abstract][Full Text] [Related]
35. Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation.
Riley P; Glenny AM; Worthington HV; Jacobsen E; Robertson C; Durham J; Davies S; Petersen H; Boyers D
Health Technol Assess; 2020 Feb; 24(7):1-224. PubMed ID: 32065109
[TBL] [Abstract][Full Text] [Related]
36. The iterative use of economic evaluation as part of the process of health technology assessment.
Sculpher M; Drummond M; Buxton M
J Health Serv Res Policy; 1997 Jan; 2(1):26-30. PubMed ID: 10180650
[TBL] [Abstract][Full Text] [Related]
37. Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project.
Wilson N; Biggs K; Bowden S; Brown J; Dimairo M; Flight L; Hall J; Hockaday A; Jaki T; Lowe R; Murphy C; Pallmann P; Pilling MA; Snowdon C; Sydes MR; Villar SS; Weir CJ; Welburn J; Yap C; Maier R; Hancock H; Wason JMS
BMC Med; 2021 Oct; 19(1):251. PubMed ID: 34696781
[TBL] [Abstract][Full Text] [Related]
38. Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model.
Crawford F; Chappell FM; Lewsey J; Riley R; Hawkins N; Nicolson D; Heggie R; Smith M; Horne M; Amanna A; Martin A; Gupta S; Gray K; Weller D; Brittenden J; Leese G
Health Technol Assess; 2020 Nov; 24(62):1-198. PubMed ID: 33236718
[TBL] [Abstract][Full Text] [Related]
39. Use of evidence in economic decision models: practical issues and methodological challenges.
Cooper NJ; Sutton AJ; Ades AE; Paisley S; Jones DR;
Health Econ; 2007 Dec; 16(12):1277-86. PubMed ID: 18034447
[TBL] [Abstract][Full Text] [Related]
40. Budget impact analysis.
Leelahavarong P
J Med Assoc Thai; 2014 May; 97 Suppl 5():S65-71. PubMed ID: 24964701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
